ZA200908479B - Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof - Google Patents

Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof

Info

Publication number
ZA200908479B
ZA200908479B ZA200908479A ZA200908479A ZA200908479B ZA 200908479 B ZA200908479 B ZA 200908479B ZA 200908479 A ZA200908479 A ZA 200908479A ZA 200908479 A ZA200908479 A ZA 200908479A ZA 200908479 B ZA200908479 B ZA 200908479B
Authority
ZA
South Africa
Prior art keywords
virosomes
compositions
cell line
influenza virus
methods
Prior art date
Application number
ZA200908479A
Other languages
English (en)
Inventor
Rinaldo Zurbriggen
Christian Moser
Silvia Rasi
Andreas Kammer
Mario Amacker
Nicole Westerfeld
Original Assignee
Pevion Biotech Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pevion Biotech Ag filed Critical Pevion Biotech Ag
Publication of ZA200908479B publication Critical patent/ZA200908479B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200908479A 2007-06-22 2009-11-30 Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof ZA200908479B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07012283A EP2014279A1 (fr) 2007-06-22 2007-06-22 Virosomes contenant de l'hémagglutinine dérivée du virus de la grippe produit par les lignées cellulaires; les compositions, les méthodes de production, l'emploi des virosomes

Publications (1)

Publication Number Publication Date
ZA200908479B true ZA200908479B (en) 2010-09-29

Family

ID=38326162

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200908479A ZA200908479B (en) 2007-06-22 2009-11-30 Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof

Country Status (11)

Country Link
US (1) US8367077B2 (fr)
EP (2) EP2014279A1 (fr)
KR (1) KR20100033969A (fr)
CN (1) CN101815505B (fr)
AT (1) ATE539736T1 (fr)
AU (1) AU2008267464B2 (fr)
CA (1) CA2689960A1 (fr)
ES (1) ES2378761T3 (fr)
RU (1) RU2441647C2 (fr)
WO (1) WO2009000433A1 (fr)
ZA (1) ZA200908479B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3009145A1 (fr) 2009-03-30 2016-04-20 Mount Sinai School of Medicine of New York University Vaccins pour le virus influenza et leurs utilisations
JP5941841B2 (ja) 2009-05-26 2016-06-29 アイカーン スクール オブ メディシン アット マウント サイナイ 周期的投与によって作製されたインフルエンザウイルスに対するモノクローナル抗体及びその使用
BR112012000826B1 (pt) 2009-07-06 2022-07-26 Variation Biotechnologies Inc Método para a preparação de vesículas
WO2011005772A1 (fr) 2009-07-06 2011-01-13 Variation Biotechnologies, Inc. Procédés pour préparer des vésicules et formulations produites à partir de ces procédés
WO2011036220A1 (fr) 2009-09-25 2011-03-31 Glaxosmithkline Biologicals S.A. Test d'immunodiffusion pour virus de la grippe
AR080171A1 (es) 2010-02-12 2012-03-21 Divergence Inc Composiciones y metodos mejorados para controlar patogenos en plantas
MX342716B (es) * 2010-02-18 2016-10-11 Sinai School Medicine Vacunas para su uso en la profilaxis y tratamiento de la enfermedad del virus de influenza.
EP3900740A1 (fr) 2010-03-30 2021-10-27 Icahn School of Medicine at Mount Sinai Vaccins contre la grippe et utilisations associées
BR112013000394B8 (pt) 2010-07-06 2022-01-18 Variation Biotechnologies Inc Composição imunogênica, uso da mesma e método para preparar a referida composição
WO2012097346A1 (fr) 2011-01-13 2012-07-19 Variation Biotechnologies, Inc. Compositions et méthodes de traitement d'infections virales
JP6085886B2 (ja) 2011-08-29 2017-03-01 国立大学法人徳島大学 Ｒｓｖ粘膜ワクチン
CN116162175A (zh) 2011-09-20 2023-05-26 西奈山伊坎医学院 流感病毒疫苗及其应用
CN104302323A (zh) 2012-01-12 2015-01-21 变异生物技术公司 用于治疗病毒感染的组合物和方法
AU2013213345A1 (en) 2012-01-27 2014-08-28 Variation Biotechnologies, Inc. Methods and compositions for therapeutic agents
KR20150104117A (ko) 2012-12-18 2015-09-14 이칸 스쿨 오브 메디슨 엣 마운트 시나이 인플루엔자 바이러스 백신 및 그의 용도
WO2014159960A1 (fr) 2013-03-14 2014-10-02 Icahn School Of Medicine At Mount Sinai Anticorps contre l'hémagglutinine du virus de la grippe et utilisations correspondantes
WO2015000831A1 (fr) * 2013-07-02 2015-01-08 Crucell Holland B.V. Procédé pour la préparation de virosomes
WO2015000832A1 (fr) * 2013-07-02 2015-01-08 Crucell Holland B.V. Procédé de préparation de virosomes
AU2016209032A1 (en) 2015-01-23 2017-08-10 Icahn School Of Medicine At Mount Sinai Influenza virus vaccination regimens
JP7237344B2 (ja) 2016-06-15 2023-03-13 アイカーン スクール オブ メディシン アット マウント サイナイ インフルエンザウイルス血球凝集素タンパク質及びその使用
US20180089722A1 (en) * 2016-09-26 2018-03-29 Justin Schulte Social media advertising system and method
US11254733B2 (en) 2017-04-07 2022-02-22 Icahn School Of Medicine At Mount Sinai Anti-influenza B virus neuraminidase antibodies and uses thereof
US11523988B2 (en) 2018-11-29 2022-12-13 Catalent U.K. Swindon Zydis Limited Oral dispersible vaccine comprising virosomes
CN113267629B (zh) * 2021-05-13 2022-06-24 广东优尼德生物科技有限公司 一种抗核抗体谱检测试剂盒及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2135406T3 (es) 1991-05-08 1999-11-01 Schweiz Serum & Impfinst Virosomas de la influenza reconstituidos inmunoestimulantes e inmunopotencializadores y vacunas que los contienen.
US5976552A (en) * 1995-04-28 1999-11-02 Protein Sciences Corporation Virus vaccines
US5989805A (en) * 1995-10-27 1999-11-23 Board Of Trustees Operating Michigan State University Immortal avian cell line to grow avian and animal viruses to produce vaccines
US5672485A (en) * 1996-08-13 1997-09-30 Regents Of The University Of Minnesota Immortalized cell lines for virus growth
EP1447080A1 (fr) 2003-02-13 2004-08-18 Bestewil Holding B.V. Procéde de production de particules de type virosome
EP1484336A1 (fr) 2003-06-02 2004-12-08 Pevion Biotech Ltd. Méthode de synthèse de peptides à constrained de conformation, peptidomimetiques et leur utilisation comme vaccins
WO2005107797A1 (fr) * 2004-03-09 2005-11-17 Chiron Corporation Vaccins antigrippaux
EP1652914A1 (fr) * 2004-10-27 2006-05-03 Berna Biotech AG Particules de type virosome comportant des antigènes du virus grippal et de virus de l'Hépatite B
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
EP1951300B1 (fr) * 2005-11-04 2011-06-22 Novartis Vaccines and Diagnostics S.r.l. Modification de l'equilibre th1/th2 dans des vaccins antigrippaux sous-unitaires avec adjuvants
NZ568211A (en) * 2005-11-04 2011-11-25 Novartis Vaccines & Diagnostic Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
NZ567978A (en) * 2005-11-04 2011-09-30 Novartis Vaccines & Diagnostic Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant
EP1797895A1 (fr) 2005-12-16 2007-06-20 Pevion Biotech Ltd. Un système adjuvant comportant des virosomes et liposomes
EP1938835A1 (fr) 2006-12-29 2008-07-02 Pevion Biotech AG Agent immunostimulant non spécifique

Also Published As

Publication number Publication date
EP2182923B1 (fr) 2012-01-04
KR20100033969A (ko) 2010-03-31
ATE539736T1 (de) 2012-01-15
US20110045057A1 (en) 2011-02-24
ES2378761T3 (es) 2012-04-17
EP2014279A1 (fr) 2009-01-14
WO2009000433A1 (fr) 2008-12-31
CN101815505B (zh) 2012-09-19
AU2008267464A1 (en) 2008-12-31
RU2441647C2 (ru) 2012-02-10
EP2182923A1 (fr) 2010-05-12
CN101815505A (zh) 2010-08-25
RU2009144125A (ru) 2011-07-27
AU2008267464B2 (en) 2013-01-17
US8367077B2 (en) 2013-02-05
CA2689960A1 (fr) 2008-12-31

Similar Documents

Publication Publication Date Title
ZA200908479B (en) Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
WO2007002008A3 (fr) Procedes et compositions permettant d'exprimer un virus a arn sens negatif dans des cellules canines
MX2010008799A (es) Proceso para estabilizar una composicion de vacuna que contiene adyuvante.
WO2012177924A3 (fr) Mutants du virus de la grippe et utilisations
AU2007240448A8 (en) Methods and compositions for expressing negative-sense viral RNA in canine cells
BR112013020767A2 (pt) composições compreendendo ácido peróxi alfa-cetocarboxílico e métodos para a produção e o uso do mesmo
BR112013032434A2 (pt) restauração dentária, método para sua produção e vidro cerâmico
BR112012018345A2 (pt) "compostos de heteroarila, bem como composições e usos dos mesmos"
WO2006063053A3 (fr) Methodes de preparation de vaccins contre la grippe
MX2012009180A (es) Variantes y composiciones que comprenden variantes con alta estabilidad en presencia de un agente quelante.
WO2010017264A3 (fr) Hydrogels d’acides nucléiques photoréticulés
WO2010004197A3 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
AR054937A1 (es) Goma de mascar biodegradable
WO2009007535A3 (fr) Derives de 7 -alkynyl-1.8-naphthyrid0nes, leur preparation et leur application en therapeutique
DOP2010000216A (es) (r)-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida cristalina
WO2009099877A3 (fr) Vecteurs de closterovirus et procédés
WO2010014574A3 (fr) Production accrue de protéases aspartiques dans des cellules fongiques filamenteuses
WO2009080806A3 (fr) Virus influenza modifié
WO2012075117A3 (fr) Conjugués de petite molécule-polymère et procédés pour leur préparation
WO2009012155A3 (fr) Préparation de virus d'arn à brin négatif par électroporation
WO2006056695A8 (fr) Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation
WO2010120058A3 (fr) Nouveau composé cyanine destiné au marquage de biomolécules et son procédé de préparation
BR112014015357A2 (pt) método para a preparação de partículas de proteína precipitada amorfa
UA91733C2 (ru) Способ получения кристаллической формы орлистата
WO2009151770A3 (fr) Formes de colchicine à l’état solide, procédés de fabrication et procédés d’utilisation associés